# DOBUTAMINE HYDROCHLORIDE
> **ANDA074206** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 1993-10-19
## Drug
- **FDA Application Number:** ANDA074206
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOBUTAMINE HYDROCHLORIDE
- **Generic name:** Dobutamine Hydrochloride
- **Active ingredients:** DOBUTAMINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PARENTERAL
- **First approval:** 1993-10-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074206)
---
*AI Analytics · CC0 1.0*